Cliff Asness’s Opus Genetics IRD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$584K Buy
+120,630
New +$501K ﹤0.01% 3356
2015
Q3
– Sell
-77
Closed -$22K – 2274
2015
Q2
$22K Sell
77
-217
-74% -$73.7K ﹤0.01% 2204
2015
Q1
$103K Sell
294
-152
-34% -$55.2K ﹤0.01% 2076
2014
Q4
$150K Hold
446
– – ﹤0.01% 2409
2014
Q3
$173K Hold
446
– – ﹤0.01% 2382
2014
Q2
$186K Sell
446
-347
-44% -$158K ﹤0.01% 2390
2014
Q1
$411K Buy
+793
New +$429K ﹤0.01% 2140

Other funds holding IRD

Cliff Asness's IRD Position: Q3 2026 in Review

Cliff Asness opened a new position in Opus Genetics (IRD) in Q3 2026: 120,630 shares worth $584K. The stake represents ﹤0.01% of the portfolio and ranks #3356 among its holdings. This is a return to the name: Cliff Asness previously reported a position in IRD as recently as Q2 2015.

Cliff Asness first reported a position in IRD in Q1 2014 and has held it in 7 quarters since. 112 funds tracked by Wall St. Rank hold IRD as of Q3 2026.

  • Cliff Asness held 120,630 shares of Opus Genetics worth $584K as of Q3 2026.
  • Opus Genetics was a new Cliff Asness position in Q3 2026.
  • Opus Genetics made up ﹤0.01% of Cliff Asness's portfolio in Q3 2026, its #3356 holding.
  • Cliff Asness first reported a position in Opus Genetics in Q1 2014 and has held it in 7 quarters since.
  • 112 funds tracked by Wall St. Rank held Opus Genetics as of Q3 2026.

Based on AQR Capital Management's 13F filing for Q3 2026, filed 16 Nov 2026.